Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat and sterile alpha motif domain-containing protein 6 (ANKS6) is a cytoplasmic scaffold protein characterized by an N-terminal region containing multiple ankyrin repeats and a C-terminal sterile alpha motif (SAM) domain[2][6]. ANKS6 localizes to the primary cilium, particularly the proximal ciliary region, where it is essential for renal and cardiovascular development[1][4][5]. It acts as a central organizing hub that links components of the nephronophthisis (NPH) module, specifically connecting NEK8 (a serine/threonine kinase), INVS (inversin), and NPHP3, thereby governing ciliary signaling processes critical for left-right symmetry, kidney morphogenesis, and heart development[1][2][3][6]. Loss-of-function mutations in ANKS6 cause nephronophthisis 16, an autosomal recessive cystic kidney disease that often presents as infantile or juvenile renal failure with associated extrarenal abnormalities, including congenital heart defects, laterality disorders (such as situs inversus), and periportal liver fibrosis[1][5]. The protein can be regulated by asparaginyl hydroxylation (via the oxygen sensor HIF1AN), which modulates complex assembly and ciliary localization[1]. ANKS6 is not known to be a direct receptor, enzyme, transporter, or common therapeutic target, and there are currently no drugs directly interacting with it in clinical practice. Its role is primarily as an adaptor/scaffold facilitating multi-protein complex formation in cilia-associated pathways underlying specific developmental and cystic diseases[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat and sterile alpha motif domain-containing protein 6 (ANKS6).